CLINICAL_TRIALS
trial_result
· 2025-12-12
Clinical Trial Update: FRDA Investigator Initiated Study (IIS) With Elamipretide [Phase 1, Phase 2]
Summary
A Phase 1/Phase 2 investigator-initiated study of Elamipretide for Friedreich Ataxia has completed, with results posted on 2025-12-12.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital of Philadelphia | Conditions: Friedreich Ataxia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-12-12